Aardvark Therapeutics, Inc.
AARD
$8.69
-$0.66-7.06%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -31.78% | 0.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.51% | 0.00% | |||
| Operating Income | -23.51% | 0.00% | |||
| Income Before Tax | -9.66% | 0.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -9.66% | 0.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.66% | 0.00% | |||
| EBIT | -23.51% | 0.00% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -9.14% | 0.00% | |||
| Normalized Basic EPS | -7.89% | 0.00% | |||
| EPS Diluted | -9.14% | 0.00% | |||
| Normalized Diluted EPS | -7.89% | 0.00% | |||
| Average Basic Shares Outstanding | 0.49% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.49% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
